{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:44:38Z","timestamp":1770957878594,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The tuberculosis vaccine, Bacille Calmette-Guerin (BCG), also affords protection against non-tuberculous diseases attributable to heterologous immune mechanisms such as trained innate immunity, activation of non-conventional T-cells, and cross-reactive adaptive immunity. Aerosol vaccine delivery can target immune responses toward the primary site of infection for a respiratory pathogen. Therefore, we hypothesised that aerosol delivery of BCG would enhance cross-protective action against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and be a deployable intervention against coronavirus disease 2019 (COVID-19). Immune parameters were monitored in vaccinated and unvaccinated rhesus macaques for 28 days following aerosol BCG vaccination. High-dose SARS-CoV-2 challenge was applied by intranasal and intrabronchial instillation and animals culled 6\u20138 days later for assessment of viral, disease, and immunological parameters. Mycobacteria-specific cell-mediated immune responses were detected following aerosol BCG vaccination, but SARS-CoV-2-specific cellular- and antibody-mediated immunity was only measured following challenge. Early secretion of cytokine and chemokine markers associated with the innate cellular and adaptive antiviral immune response was detected following SARS-CoV-2 challenge in vaccinated animals, at concentrations that exceeded titres measured in unvaccinated macaques. Classical CD14+ monocytes and V\u03b42 \u03b3\u03b4 T-cells quantified by whole-blood immunophenotyping increased rapidly in vaccinated animals following SARS-CoV-2 challenge, indicating a priming of innate immune cells and non-conventional T-cell populations. However, viral RNA quantified in nasal and pharyngeal swabs, bronchoalveolar lavage (BAL), and tissue samples collected at necropsy was equivalent in vaccinated and unvaccinated animals, and in-life CT imaging and histopathology scoring applied to pulmonary tissue sections indicated that the disease induced by SARS-CoV-2 challenge was comparable between vaccinated and unvaccinated groups. Hence, aerosol BCG vaccination did not induce, or enhance the induction of, SARS-CoV-2 cross-reactive adaptive cellular or humoral immunity, although an influence of BCG vaccination on the subsequent immune response to SARS-CoV-2 challenge was apparent in immune signatures indicative of trained innate immune mechanisms and primed unconventional T-cell populations. Nevertheless, aerosol BCG vaccination did not enhance the initial clearance of virus, nor reduce the occurrence of early disease pathology after high dose SARS-CoV-2 challenge. However, the heterologous immune mechanisms primed by BCG vaccination could contribute to the moderation of COVID-19 disease severity in more susceptible species following natural infection.<\/jats:p>","DOI":"10.3389\/fimmu.2021.801799","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T06:01:35Z","timestamp":1644386495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques"],"prefix":"10.3389","volume":"12","author":[{"given":"Andrew D.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Sarfas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra L.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Bewley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Churchward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Fotheringham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Gkolfinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Handley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly E.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Kennard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Longet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Mabbutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Moffatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yper","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bodman-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergus","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Salguero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"B1","unstructured":"Coronavirus (COVID-19) Dashboard."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008410117","article-title":"BCG Vaccine Protection From Severe Coronavirus Disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12098-020-03371-3","article-title":"BCG Vaccination Policy and Protection Against COVID-19","volume":"87","author":"Meena","year":"2020","journal-title":"Indian J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/all.14345","article-title":"Is Global BCG Vaccination-Induced Trained Immunity Relevant to the Progression of SARS-CoV-2 Pandemic","volume":"75","author":"Gursel","year":"2020","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/all.14344","article-title":"Is BCG Vaccination Affecting the Spread and Severity of COVID-19","volume":"75","author":"Ozdemir","year":"2020","journal-title":"Allergy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG Vaccination on Childhood Tuberculous Meningitis and Miliary Tuberculosis Worldwide: A Meta-Analysis and Assessment of Cost-Effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02869","article-title":"Non-Specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations","volume":"9","author":"Uthayakumar","year":"2018","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.157537","article-title":"The Non-Specific Effects of Vaccines","volume":"95","author":"Shann","year":"2010","journal-title":"Arch Dis Child"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin Induces NOD2-Dependent Nonspecific Protection From Reinfection via Epigenetic Reprogramming of Monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-Induced Trained Immunity in NK Cells: Role for Non-Specific Protection to Infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol Orlando Fla"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.743924","article-title":"Cheap and Commonplace: Making the Case for BCG and \u03b3\u03b4 T Cells in COVID-19","volume":"12","author":"Morrison","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.692729","article-title":"BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity","volume":"12","author":"Eggenhuizen","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects Against Experimental Viral Infection in Humans Through the Induction of Cytokines Associated With Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2","volume":"11","author":"Covi\u00e1n","year":"2020","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1038\/s41598-021-87731-9","article-title":"Reconcile the Debate Over Protective Effects of BCG Vaccine Against COVID-19","volume":"11","author":"Fu","year":"2021","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016733117","article-title":"Lack of Evidence for BCG Vaccine Protection From Severe COVID-19","volume":"117","author":"Arlehamn","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.632478","article-title":"The BCG Vaccine for COVID-19: First Verdict and Future Directions","volume":"12","author":"Gonzalez-Perez","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG Delivery Strategies Improve Protection Against Mycobacterium Tuberculosis in Non-Human Primates: Protection Associated With Mycobacterial Antigen-Specific CD4 Effector Memory T-Cell Populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of Tuberculosis in Macaques After Intravenous BCG Immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1973.107.3.351","article-title":"Protection of Monkeys Against Airborne Tuberculosis by Aerosol Vaccination With Bacillus Calmette-Guerin","volume":"107","author":"Barclay","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"B22","article-title":"Superiority of Intravenously Administered BCG and BCG Cell Walls in Protecting Rhesus Monkeys (Macaca Mulatta) Against Airborne Tuberculosis","volume":"143","author":"Anacker","year":"1972","journal-title":"Z F\u00fcr Immun Exp Klin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/pharmaceutics12050394","article-title":"Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. Tuberculosis Challenge in Rhesus Macaques","volume":"12","author":"White","year":"2020","journal-title":"Pharmaceutics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1128\/CVI.00289-15","article-title":"An Evaluation of the Immunogenicity of BCG, Delivered by Aerosol to the Lungs of Macaques","volume":"22","author":"White","year":"2015","journal-title":"Clin Vaccine Immunol CVI"},{"key":"B25","unstructured":"Aerosol BCG Challenge Trial in Healthy UK Adults."},{"key":"B26","unstructured":"Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100185","article-title":"Stronger Induction of Trained Immunity by Mucosal BCG or MTBVAC Vaccination Compared to Standard Intradermal Vaccination","volume":"2","author":"Vierboom","year":"2021","journal-title":"Cell Rep Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41467-021-21389-9","article-title":"Comparison of Rhesus and Cynomolgus Macaques as an Infection Model for COVID-19","volume":"12","author":"Salguero","year":"2021","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.06.057","article-title":"One or Two Dose Regimen of the SARS-CoV-2 Synthetic DNA Vaccine INO-4800 Protects Against Respiratory Tract Disease Burden in Nonhuman Primate Challenge Model","volume":"39","author":"Gooch","year":"2021","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s42003-021-02443-0","article-title":"ChAdOx1 Ncov-19 Protection Against SARS-CoV-2 in Rhesus Macaque and Ferret Challenge Models","volume":"4","author":"Lambe","year":"2021","journal-title":"Commun Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg7996","article-title":"Immunological and Pathological Outcomes of SARS-CoV-2 Challenge Following Formalin-Inactivated Vaccine in Ferrets and Rhesus Macaques","volume":"7","author":"Bewley","year":"2021","journal-title":"Sci Adv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal Models for COVID-19","volume":"586","author":"Mu\u00f1oz-Fontela","year":"2020","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba8399","article-title":"A Single Dose of ChAdOx1 MERS Provides Protective Immunity in Rhesus Macaques","volume":"6","author":"van Doremalen","year":"2020","journal-title":"Sci Adv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/srep43478","article-title":"The Influence of Haemoglobin and Iron on In Vitro Mycobacterial Growth Inhibition Assays","volume":"7","author":"Tanner","year":"2017","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological Assessment of Hospitalized Patients With COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 Infection Protects Against Rechallenge in Rhesus Macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00536-y","article-title":"Quantification of SARS-CoV-2 Neutralizing Antibody by Wild-Type Plaque Reduction Neutralization, Microneutralization and Pseudotyped Virus Neutralization Assays","volume":"16","author":"Bewley","year":"2021","journal-title":"Nat Protoc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 Vaccines Strategies: A Comprehensive Review of Phase 3 Candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.7.3942","article-title":"Adjuvant-Guided Type-1 and Type-2 Immunity: Infectious\/Noninfectious Dichotomy Defines the Class of Response","volume":"162","author":"Yip","year":"1999","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.trivac.2014.08.002","article-title":"Non-Specific Immunity of BCG Vaccine: A Perspective of BCG Immunotherapy","volume":"3","author":"Talat Iqbal","year":"2014","journal-title":"Trials Vaccinol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex Immune Dysregulation in COVID-19 Patients With Severe Respiratory Failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: Current State of the Science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity Against Tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1159\/000355628","article-title":"Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1\/Th17 Responses and Innate Trained Immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune Determinants of COVID-19 Disease Presentation and Severity","volume":"27","author":"Brodin","year":"2021","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6261","article-title":"Systems Biological Assessment of Immunity to Mild Versus SevereCOVID-19 Infection in Humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIAB005","article-title":"EarlyDifferences in Cytokine Production by Severity of Coronavirus Disease 2019","volume":"223","author":"Tjan","year":"2021","journal-title":"J Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50569","article-title":"Isolation and Rapid Sharing of the 2019 Novel Coronavirus (SARS-CoV-2) From the First Patient Diagnosed With COVID-19 in Australia","volume":"212","author":"Caly","year":"2020","journal-title":"Med J Aust"},{"key":"B51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0023677218757815","article-title":"Refinement and Reduction Through Application of a Quantitative Score System for Estimation of TB-Induced Disease Burden Using Computed Tomography","volume":"52","author":"Sharpe","year":"2018","journal-title":"Lab Anim"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.801799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T09:40:32Z","timestamp":1674726032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.801799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2021.801799"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.801799","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"article-number":"801799"}}